Scan to Download ios&Android APP

Trade Gritstone bio, Inc. - GRTS CFD

2.69
2.66%
0.05
Low: 2.62
High: 2.81
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

Gritstone bio, Inc. live chart

Still looking for a broker you can trust?
Capital.com Group
400,000+

Traders

90,000+

Active clients monthly

$65,000,000+

Monthly investing volume

$29,000,000+

Withdrawn each month

  • Summary
  • Historical Data
Trading Conditions
Long position overnight fee
-0.0225%
Short position overnight fee
-0.0219%
Overnight fee time
21:00 (UTC)
Min traded quantity
1
Currency
USD
Margin
20%
Stock exchange
United States of America
Commission on trade
0%
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 23, 2022 2.63 0.12 4.78% 2.51 2.63 2.42
Jun 22, 2022 2.50 0.23 10.13% 2.27 2.61 2.25
Jun 21, 2022 2.35 0.10 4.44% 2.25 2.39 2.23
Jun 17, 2022 2.19 0.14 6.83% 2.05 2.30 2.05
Jun 16, 2022 2.11 0.01 0.48% 2.10 2.13 2.00
Jun 15, 2022 2.16 0.13 6.40% 2.03 2.20 2.03
Jun 14, 2022 2.08 0.01 0.48% 2.07 2.12 2.04
Jun 13, 2022 2.06 -0.11 -5.07% 2.17 2.18 2.00
Jun 10, 2022 2.23 0.02 0.90% 2.21 2.30 2.17
Jun 9, 2022 2.24 -0.05 -2.18% 2.29 2.32 2.21
Jun 8, 2022 2.31 0.13 5.96% 2.18 2.37 2.18
Jun 7, 2022 2.24 0.23 11.44% 2.01 2.24 1.98
Jun 6, 2022 2.03 -0.10 -4.69% 2.13 2.17 1.98
Jun 3, 2022 2.11 0.09 4.46% 2.02 2.13 1.98
Jun 2, 2022 2.06 0.13 6.74% 1.93 2.08 1.87
Jun 1, 2022 1.96 -0.02 -1.01% 1.98 1.99 1.85
May 31, 2022 2.00 0.08 4.17% 1.92 2.31 1.92
May 27, 2022 1.82 0.04 2.25% 1.78 1.82 1.77
May 26, 2022 1.76 0.05 2.92% 1.71 1.80 1.69
May 25, 2022 1.76 0.01 0.57% 1.75 1.78 1.69

Content 2
Content 2

Key Stats

Prev. Close* 2.63
Open* 2.66
Day's Range* 2.62 - 2.62
1-Year Change* -1.85%
Volume N/A
Average Vol. (3m) 27.6853
52 wk Range N/A
Market Cap 152.179
P/E Ratio N/A
Shares Outstanding 72.81M
Revenue 15.712
EPS -1.58217
Dividend (Yield %) N/A
Beta 0.69011
Next Earnings Date Aug 3, 2022

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Gritstone bio, Inc. Company profile

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types and infectious diseases. Its lead product candidate is GRANITE, which is in Phase I/II clinical trial for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors, including metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and other mutation-positive tumors. Gritstone Oncology, Inc. has a strategic collaboration with bluebird bio, Inc. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was founded in 2015 and is headquartered in Emeryville, California.
Industry: Biopharmaceuticals

5959 Horton Street, Suite 300
EMERYVILLE
CALIFORNIA 94608
US

People Also Watch

Bitcoin to US Dollar

21,275.15 Price
+2.150% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 21:00 (UTC)
Spread 60.00

Market analysis

Gritstone bio, Inc. (GRTS) Stock Jumps 4.38%: Will It Continue to Soar?

Gritstone bio, Inc. (GRTS) stock is up 4.38% in the last day. For details on what happened in the market, see our analysis.

07:00, 24 June 2022

Learn more about

Still looking for a broker you can trust?

Join the 400.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading